PTPN5
Tyrosine-protein phosphatase non-receptor type 5
Also known as: PTN5_HUMAN, PTPSTEP, STEP, STEP61
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P54829
- Gene
- PTPN5
- Ensembl
- ENSG00000110786
- Chromosome
- 11
- Canonical length
- 565 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
Enables phosphotyrosine residue binding activity. Predicted to be involved in signal transduction. Predicted to act upstream of or within protein dephosphorylation. Predicted to be located in membrane and nucleoplasm. Predicted to be active in cell junction; cytosol; and plasma membrane. Biomarker of Alzheimer's disease. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
565 residues, UniProt reviewed canonical sequence.
>P54829|PTPN5
1 MNYEGARSER ENHAADDSEG GALDMCCSER LPGLPQPIVM EALDEAEGLQ DSQREMPPPP
61 PPSPPSDPAQ KPPPRGAGSH SLTVRSSLCL FAASQFLLAC GVLWFSGYGH IWSQNATNLV
121 SSLLTLLKQL EPTAWLDSGT WGVPSLLLVF LSVGLVLVTT LVWHLLRTPP EPPTPLPPED
181 RRQSVSRQPS FTYSEWMEEK IEDDFLDLDP VPETPVFDCV MDIKPEADPT SLTVKSMGLQ
241 ERRGSNVSLT LDMCTPGCNE EGFGYLMSPR EESAREYLLS ASRVLQAEEL HEKALDPFLL
301 QAEFFEIPMN FVDPKEYDIP GLVRKNRYKT ILPNPHSRVC LTSPDPDDPL SSYINANYIR
361 GYGGEEKVYI ATQGPIVSTV ADFWRMVWQE HTPIIVMITN IEEMNEKCTE YWPEEQVAYD
421 GVEITVQKVI HTEDYRLRLI SLKSGTEERG LKHYWFTSWP DQKTPDRAPP LLHLVREVEE
481 AAQQEGPHCA PIIVHCSAGI GRTGCFIATS ICCQQLRQEG VVDILKTTCQ LRQDRGGMIQ
541 TCEQYQFVHH VMSLYEKQLS HQSPELocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTPN5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 301 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 301 nTPM
- cerebral cortex: 72 nTPM
- hypothalamus: 43 nTPM
- amygdala: 30 nTPM
- hippocampal formation: 28 nTPM
- midbrain: 12 nTPM
Single-cell type
- brain inhibitory neurons: 164 nCPM
- other brain neurons: 65 nCPM
- brain excitatory neurons: 48 nCPM
- undifferentiated spermatogonia: 18 nCPM
- oocytes: 14 nCPM
- oligodendrocyte progenitor cells: 12 nCPM
Immune cell
- basophil: 0.2 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 378 nTPM
- cerebral cortex: 159 nTPM
- white matter: 103 nTPM
- hypothalamus: 98 nTPM
- amygdala: 91 nTPM
- thalamus: 81 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.12
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tyrosine-specific protein phosphatase, PTPase domain
- Tyrosine-specific protein phosphatases domain
- Protein-tyrosine phosphatase, catalytic
- Protein-tyrosine phosphatase, KIM-containing
- Protein-tyrosine phosphatase, active site
- Protein-tyrosine phosphatase, receptor type R/non-receptor type 5
- Protein-tyrosine phosphatase-like
- Protein-tyrosine phosphatase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTPN5 as an antibody target. Whether an autoantibody or antibody against PTPN5 could matter depends on whether native PTPN5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTPN5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTPN5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...